Sunday, September 11, 2016 17:00-18:30 Registration 18:30-20:00 Welcome Reception Monday, September 12, 2016 08:00-09:00 Registration & Refreshments & Exhibition Visit Greetings: 09:00-09:25 Yossi Bornstein, CEO Shizim, Chairman Cann10 Prof. Yehuda Shoenfeld, Head Zbludowicz Center for Autoimmune Diseases, Chaim Sheba Medical Center at Tel-Hashomer, Affiliated to Tel-Aviv University, Israel Prof. Raphael Mechoulam, Institute for Drug Research, The Hebrew University of Jerusalem, Israel 09:25-09:55 The Cannabinoids: Looking Back and Ahead Prof. Rudolf Brenneisen, Head of Department of Clinical Research (DCR), University of Bern 09:55-10:15 Guest Speaker: Pharmacokinetics, Application Forms and Quality of Cannabinoids - A Real Challenge 10:15-10:30 Coffee Break & Exhibition Visit Science and Medical Track Technology and Commercial Track Agriculture and Industry Track The Latest in Cannabis Research Multidisciplinary Technologies for Medical Cannabis Recent Trends in Cannabis Cultivation Use 10:30-12:30 Chair: Co-Chairs: Prof. Roger G. Pertwee, UK & Prof. Co-Chairs: Prof. Aharon (Ari) Eyal, Israel & Dr. Co-Chairs: Dr. Oded Sagee, Israel & Dr. Noam Zvi Bentwich, Israel Avraham (Avi) Arbel, Israel Chehanovsky, Israel Prof. Zvi Bentwich, Center of Tropical Diseases Center and Dr. Avraham (Avi) Arbel, Head, Department of Growing Dr. Oded Sagee, Founder & Co-CEO AquaAgro Lab, Israel AIDS, Ben Gurion University, and Chief Scientist Tikun Olam Production and Environmental Engineering, The Volcani Center The Use of Plant Growth Regulators in Cannabis Ltd. MOAG, Israel Cultivation History and Future of Cannabis Clinical Research Advanced Climate Control Systems for Year-Round Cannabis Greenhouses Prof. Roger G. Pertwee, MA, DPhil, DSc, HonFBPhS Dr. Shmuel Cohen, Lead Scientist Izun Pharmaceuticals Ltd, Dr. Noam Chehanovsky, Cannabis Geneticist and Breeder, Institute of Medical Sciences University of Aberdeen, Israel/USA Seed Specialist, Kedem Seeds, Israel Scotland, UK From Plant to Product: Design of A Robust and Cannabis Genetics: Past and Future Prospects Pharmacological Actions and Potential Novel Consistent Cannabis Medication for Pain Using a Therapeutic Uses of Plant Cannabinoids: Great Unique Formulation Technology to Capture the Expectations Complete Cannabinoid Complex Mr. Gilad Livni, Genetic Development and Consultant, Seach Dr. David (Dedi) Meiri, Assistant Professor, Heads the Prof. Richard Peet, Executive Vice President, Chief Ltd., Israel "Laboratory of Cancer Biology and Cannabinoid Research", Intellectual Property Counsel, Teewinot Life Sciences Cannabis Breeding: Present Trends and the Future Technion, Israel Institute of Technology, Israel Corporation, USA From Anecdotal Knowledge to Evidence Based - The Biosynthesis of Cannabinoids - Commercial Process for Future of Cannabis Research Biosynthetic Production of authentic THCA, CBDA and CBCA Cannabinoids Prof. Asaph Aharoni, Scientist at the Department of Plant and Environmental Sciences, Faculty of Dr. Yossi (Joseph) Tam, Head, Obesity and Metabolism Prof. Aharon (Ari) Eyal, CSO, Bazelet Pharma, Israel Biochemistry, Weizmann Institute of Science, Israel Laboratory, The Hebrew University of Jerusalem, Israel Cannabis: Industrial Challenges, Business Opportunities and Science Peripheral vs Global Cannabinoid - 1 Receptor What Can You Do with Cannabis? Lessons from Model Blockade for the Treatment of the Metabolic Plants Syndrome Prof. Abraham (Avi) J. Domb, Professor for Medicinal Mr. Emanuel Stanciu , Sales and Application Dr. Nirit Bernstein, Plant Physiology and nutrition Institute Chemistry and Biopolymers at the Faculty of Medicine of the Manager, Organic Chemistry Department, Dr Golik, Israel of Soil Water and Environmental Sciences, Volcani Center, Hebrew University, Jerusalem College of Engineering The latest Developments and Technologies in Cannabis Israel and Prof. Amnon Hoffman, Chairman, Division of Clinical Extraction, Cannabinoids Separation and Encapsulation Elicitation Treatments for Stimulation and Stabilization Pharmacy Head, Pharm., The Hebrew University of of Cannabinoids Production in Cannabis Jerusalem, Israel Pharmaceutical Challenges in the Delivery of THC and CBD Panel Discussion: Moderated by: Prof. Zvi Bentwich Mr. Nadav Eyal, Co-Founder & CEO of Eybna Technologies, Subjects of Discussion: Israel 1. Will the Future of Medical Cannabis Research be The Personal Cannabis: The Next Strain of Cannabis Based on: Synthetic Material or Cannabis Extract? based Products 2. What are Today's Priorities in Medical Cannabis Areas of Research? 12:30-12:40 Intermission Free Oral Communication 1 Free Oral Communication 2 Free Oral Communication 3 12:40-13:30 Molecular Aspects and Recent Research of Medical Indications and Clinical Trials of Medical Aspects in Health Care Policy and Commercialization Cannabinoids Cannabis Dr. István Ujváry, Hungary Prof. Irit Akirav, Israel Dr Jonathan Grunfeld, Israel The Cannabidiol Enigma: are The Metabolites of CBD Targeting the Endocannabinoid System for Stress- Medical Use of Cannabis: A Conflict of Paradigms, Pharmacologically Active? Related Disorders Current processes and decisions to be made Dr. Gil Lewitus, Israel Leah Bisiani, Australia Dr. Ilan Nachim, Canada The Cannabinoids Diversity in the Various Cannabis The Potential Scope of Medicinal Cannabis as an Cannabinoids: a Canadian Experience Strains and Their Impact on Medical Use Alternative to Chronic Pain Management Regimes for Older Australians Living Within the Aged Care Sector Dr. Ronen Shemesh, Israel Cannabinoid System as Targets for Fertility Dr. Daphna Heffetz, Israel Keren Hagai, Israel Enhancement Clinical Study Results of Innovative Oral Pill Patent Data Analysis: A Predictive Tool for Medical Formulations Containing Standardized Cannabinoids Cannabis Investors and Innovators Mixture for MS Symptomatic Treatment Daphna katz, Israel Cannabis and the BBB – A Possible New Approach for Dr. Debra Kimless, USA Mark Fishman, Israel Neurologic Autoimmune Diseases? Palliative Care to Remission: Use of Low Dose Indoor Cultivation for Medical Cannabis is a Must and Cannabis Oil in an 8 Year Old, all Patient with Now it`s Economically Feasible aromatic constituents Metastasis 13:30-14:30 Lunch Break & Exhibition Visit Panel Discussion: Who's afraid of Medical Cannabis? Panel Participants: Dr. Bareket Schiff-Keren, Pain Management Specialist, Israel; Dr. Bat Sheva Porat Katz, Tel-Aviv District Health Bureau, Ministry of Health, Israel, Prof. Elyad 14:30-15:45 Davidson, Director Pain Relief Unit, Dept. Of Anesthesia & CCM, Hadassah University Hospital, Israel; Mr. David Pappo, Chairman of the Pharmaceutical Association of Israel Central Council, Israel; Dana Bar-on, Medical Cannabis Association, Israel Yuval (Tuby) Zolotov, M.H.A PhD Candidate, School of Public Health, University of Haifa, Israel : Survey: Assessment of Israeli Physicians Knowledge, Experience and Attitudes towards Medical Cannabis 15:45-16:00 Coffee Break & Exhibition Visit Science and Medical Track Technology and Commercial Track Cannabis and Oncology - Is Cannabis on the Path Towards Curing Cancer Cannabis Market 16:00-17:20 Co-Chairs: Prof. Reuven Or, Israel & Prof. Gil Bar-Sela, Israel Prof. Reuven Or, Director of The Department of Bone Marrow Transplantation Cancer Immunotherapy & Dr. Dan Dvoskin, Financial – Agricultural senior Advisor, Israel Immunobiology Research Center Hadassah University Hospital, Israel Medical Cannabis Production in Israel in the New Governmental The Use of Cannabis-Based Medicines in Hematopoietic Stem Cell Transplantation: Lessons from Policy: Economic Impacts the Clinic and the Laboratory Prof. Gil Bar-Sela, Deputy Director of the Division of Oncology at Rambam Health Care Campus, TBA Head of the Palliative and Supportive Oncology Unit, Israel Cannabis and Synthetic Cannabinoids for Palliative Indication in Cancer Patients 17:00-18:00 Prof. Amos Toren, Head of Pediatric Hemato-Oncology at the Sheba Medical Center - Tel Hashomer, Israel Workshop: Cannabis Quality Assessment In vitro and in vivo Efficacy of Non-Psychoactive Cannabidiol in Neuroblastoma Sébastien Béguerie, Founder & CEO Alpha-CAT, Coordinator, International Medical Cannabis Patient Coalition (IMCPC), France Q&A Tuesday, September 13, 2016 08:00-09:00 Registration & Refreshments & Exhibition Visit Plenary Session: Mr. Mike Dunafon, Mayor of Glendale, Colorado, USA The Politics of Marijuana: Myths & Misinformation - The Colorado Experience 09:00-10:30 Tamar Zandberg MK, (Meretz), Chair Knesset Committee on Drug and Alcohol Abuse, Israel Israeli Medical Cannabis Policy – How to Break Free from the Stigma? TBA 10:30-11:00 Coffee Break & Exhibition Visit Science and Medical Track Technology and Commercial Track Cannabis Treatments Benefits vs. Risks Is Medical Cannabis a Passing Trend or Sustainable Business? 11:00-12:20 Chair: Prof. Yehuda Shoenfeld, Israel Co-Chairs: David Spitz, USA & Ayelet Torem, Israel Prof. Yehuda Shoenfeld, Head of The Zabludowicz Center for Autoimmune Diseases, Sheba Medical Center Mr. David Spitz, Hi-End Medical Cannabis Grower in Colorado, USA - Tel Hashomer, Israel Marijuana based Products - Product Strategies Cannabis in Autoimmune Diseases Ayelet Torem, APM co. Partner at High Tech and Venture Capital Prof. Ruth Gallily, Department of Immunology, Hebrew University, Jerusalem, Israel Department, Israel Anti-Inflammation Properties of Cannabidiol vs. Cannabis Extract Participant: Entrepreneur, International VC, Israeli VC, Angel Panel Discussion: Investments in Medical